Jaron King, MS, is the surveillance coordinator for the South Carolina Division of Tobacco Prevention and Control. He is also a first year PhD student at the University of South Carolina’s Arnold School of Public Health. His research experience has been in health communication and is chiefly responsible for tobacco surveillance activities in his current… Read more »
Dr. Healton is the dean of the School of Global Public Health at New York University, Director of the Global Institute of Public Health and Professor of Public Health Policy and Management. Prior to this appointment, Dr. Healton served as President and Chief Executive Officer of Legacy, the leading national foundation dedicated to tobacco control…. Read more »
Dr Alex Wodak is a physician who was Director of the Alcohol and Drug Service, St. Vincent’s Hospital, Sydney (1982-2012) but has now retired. Major interests include prevention of HIV among people who inject drugs, prevention of alcohol problems and drug policy reform. Dr. Wodak is President of the Australian Drug Law Reform Foundation and… Read more »
Michael Pesko is a health economist and an Associate Professor in the Department of Economics at Georgia State University. Dr. Pesko’s research uses retrospectively-collected data and quasi-experimental methods to evaluate health policy changes. Dr. Pesko is particularly interested in policy changes affecting the use of e-cigarettes (see: e-cigarette research summary). Dr. Pesko has published over 40 peer… Read more »
Described by Rolling Stone as “the point man” for drug policy reform efforts and “the real drug czar,” Ethan Nadelmann is widely regarded as the outstanding proponent of drug policy reform both in the United States and abroad. He founded and directed (from 2000 to 2017) the Drug Policy Alliance. Ethan was born in New York City… Read more »
Scott J. Leischow joined Arizona State University in June 2017, and is a Professor and the Director of Clinical and Translational Science. Prior to that, Leischow was at the Mayo Clinic Arizona from 2012-2017, where he led the Research on Health Equity and Community Health (REACH) Program and co-led cancer prevention and control within the Mayo Clinic… Read more »
Jennifer Pearson is an Associate Professor in Health Administration and Policy in the School of Public Health at the University of Nevada, Reno. Broadly, her research focuses on how regulation of tobacco and cannabis product characteristics, packaging, and advertising affects consumer behavior and public health outcomes. Dr. Pearson has authored over 100 scientific peer-reviewed scientific… Read more »
Stefanie Miller is an investment analyst with FiscalNote Markets in Washington, D.C., where she leads the tobacco, cannabis, politics and fiscal policy practice areas. She specializes in the legal and political risks to the tobacco sector stemming from FDA tobacco regulations, Congressional tobacco control efforts, innovative products entering the nicotine market, and incumbent public health… Read more »
Dr. Ahluwalia is a physician, public health scientist and professor at Brown University’s Schools of Public Health and Medicine, and is the Associate Director for Population Sciences at the Brown Cancer Center. He has been in academic medicine since 1992 and has been a practicing physician, faculty member, department chair, Associate Dean and Center Director in medical… Read more »
Matthew R. Holman, Ph.D. is currently Director of the Office of Science at the Center for Tobacco Products (CTP) of the U.S. Food and Drug Administration (FDA). He was appointed to that position in January 2017. The Office of Science at CTP is responsible for identifying, developing, and enhancing the science related to tobacco products,… Read more »
Recent Comments